Correspondence
In Brief Nuber et al. demonstrate that tetramers are required for the physiological state of a-synuclein in vivo by developing a novel mouse model of Parkinson's disease based on destabilizing tetramers. This produces neuropathology and a progressive motor syndrome resembling PD.
INTRODUCTION
Parkinson's disease (PD), dementia with Lewy bodies (DLB), and related neurodegenerative disorders involve the age-dependent accumulation of a-synuclein (aS) in cytoplasmic inclusions termed Lewy bodies and neurites. In PD, the inclusions occur in midbrain dopaminergic and diverse cortical neurons, dysfunction and degeneration of which underlie the motor and cognitive impairments (Surmeier et al., 2017) . Point mutations and duplica-tions in the SNCA gene cause familial forms of PD (fPD) and DLB with extensive brainstem, striatal, and cortical aS cytopathology and neuronal loss (Fujishiro et al., 2013) .
Studies of the normal cellular function of aS suggest that it transiently interacts with vesicle membranes and regulates the trafficking and exocytosis of synaptic and other vesicles (Wang et al., 2014; Logan et al., 2017; Burré et al., 2010) . On the other hand, in vitro experiments indicate that abnormal aS oligomers can bind to and perturb membrane function and contribute to cell death (Fusco et al., 2017; Sharon et al., 2003; Winner et al., 2011) . However, some fPD subjects carry aS missense mutations (e.g., A30P, G51D) that have less membrane affinity than the wildtype (WT) protein and may therefore induce cytotoxicity via aqueously soluble oligomers (Ysselstein et al., 2015) , arguing for a pathogenic role of aggregation-prone monomers independent of their abnormal association with membranes. Understanding the conversion of physiological aS to pathogenic oligomers requires knowledge of the normal forms of the protein in healthy neurons. Beginning in 2011, our laboratory described and characterized a previously unrecognized native form of cellular aS: metastable, a-helically folded tetramers of $58 kDa (4 3 14,502 monomers) (Bartels et al., 2011; Dettmer et al., 2013 Dettmer et al., , 2015a Dettmer et al., , 2015b . Heretofore, cellular aS had been described as ''natively unfolded'' monomers that could aggregate into bsheet-rich pathological oligomers. Although the initial description of cellular a-helical tetramers and related multimers proved controversial (Fauvet et al., 2012; Burré et al., 2013) , other laboratories also obtained evidence for the existence of apparently physiological tetramers and related conformers Westphal and Chandra, 2013; Burré et al., 2014) .
We hypothesize that aS normally occurs in a dynamic equilibrium of unfolded $14-kDa monomers with a-helically folded $60-kDa tetramers. We reported that aS purified under nondenaturing conditions from human (hu) erythrocytes and neuroblastoma cells occurs in part as tetramers that resist aggregation in vitro (Bartels et al., 2011) . Intact-cell crosslinking showed that not only aS but also the non-pathogenic bS and gS homologs occur as both tetramers and monomers . In accord, the insertion of tetramer-abrogating mutations into the 6 imperfectly repeated KTKEGV motifs slowed the kinetics of vesicle exocytosis conferred by WT aS in living neurons, suggesting that tetramers participate in a normal function of aS in vesicle trafficking (Wang et al., 2014) . Regarding the relevance of tetramers to disease, we found that all fPD-causing aS missense mutations decrease the physiological tetramer:monomer (T:M) ratio in neurons, thereby increasing the levels of aggregation-prone monomers . One of these fPD-causing mutations (E46K) occurs within a KTKEGV motif that is imperfectly repeated 6-9 times and helps confer helicity to aS in vitro (Davidson et al., 1998) .
Based on this information, we examined the effect of amplifying the tetramer/monomer shift induced by E46K by adding one or two homologous E-to-K mutations into the adjacent KTKEGV repeats (i.e., at residues 35 and/or 61). This resulted in an E-to-K dose-dependent loss of tetramers and gain of monomers in cells . The resultant K mutant monomers displayed increased interaction with vesicular membranes, leading to round cytoplasmic inclusions of clustered vesicles associated with neurotoxicity .
The distinct properties of aS tetramers versus monomers as regards transient lipid binding (Bartels et al., 2011) were underscored by the finding that unfolded aS monomers but not purified cellular tetramers could bend and stabilize vesicle membranes in vitro (Westphal and Chandra, 2013) , which may in turn inhibit membrane fusion events during exocytosis (Wang et al., 2014) . In accord, another report provided evidence for a physiological function of aS multimers (tetramers, octamers) in facilitating SNARE complex formation and vesicle fusion (Burré et al., 2014) . The relevance of the tetramers for neuronal physiology is further supported by the recent discovery that hu neurons bearing loss-of-function mutations in glucocerebrosidase (GBA1) that cause Gaucher's disease (Brady et al., 1965) and PD (e.g., Aharon-Peretz et al., 2004) have decreased T:M ratios of their WT aS protein, and genetic or pharmacological restoration of normal glucosylceramide levels corrects this decrease (Kim et al., 2018) .
These steadily accruing data notwithstanding, the biological importance of the aS T:M equilibrium remains controversial. To establish its role in vivo, we correlated tetramer-abrogating mutants of aS with cytotoxicity in neuronal culture and identified a triple mutant (E35K + E46K + E61K) that more robustly decreases tetramers and induces cytotoxicity than E46K alone. Based on this culture finding, we generated transgenic mouse lines that express this tetramer-lowering ''3K'' aS mutation. When compared to WT and fPD E46K (''1K'') mutant mice, the 3K mutant more strongly shifts tetramers to excess monomers, leading to striking neuropathological, biochemical, and behavioral features resembling PD, including degeneration of DAergic striatal and cortical fibers and neurons, reduced DA levels, and an age-dependent, progressive motor phenotype of tremor, decreased limb function, and abnormal gait that is transiently improved by L-DOPA. The tetramer-incompetent monomers become insoluble, abnormally phosphorylated, and C-terminally truncated (as in PD) and accumulate at vesicles in association with lipid-rich autofluorescent deposits (lipofuscin) . This unique PD model shows that aS tetramerization is a required physiological process and its chronic impairment results in key features of PD, thus both validating and enabling the novel therapeutic approach of stabilizing tetramers to prevent PD, DLB, and other synucleinopathies.
RESULTS
Amplifying the E46K fPD Mutation In Vivo Shifts aS Tetramers toward Excess Full-Length and Truncated Monomers and Enhances aS Membrane Association Our previous studies showed that all PD-causing aS missense mutations decrease the physiological T:M ratio in neurons and that inserting tetramer-lowering E/K mutations into the KTKEGV motifs induces cytotoxicity and inclusions in cell culture (Dettmer et al., , 2015b (Table S1 ). To enhance PD-like phenotypes in aS tg mice, which usually display a rather late onset of PD-relevant motor symptoms and little or no L-DOPA responsiveness (Table S2) , we first confirmed the correlation between tetramer abrogation and neurotoxicity by expressing each single E/K mutant and their amplification (3K) versus WT aS in hu M17D neuroblastoma cells. We analyzed the ratio of aS tetramers (designated aS60) and related multimers (designated aS80 and aS100) to monomers (designated aS14). Each of the 3 E/K mutants alone significantly reduced the WT tetramer to monomer (T:M) ratio in cells by $40%, but the 3K mutant markedly exacerbated this to $90% (Figures 1A and 1B) . Associated cytotoxicity was then quantified in 3 distinct assays: PARP cleavage ( Figures 1C and 1D ), cell confluence (Figure 1E, upper panel) , and lactate dehydrogenase (LDH) release ( Figure 1E , lower panel). The single K mutations increased toxicity significantly in the first and third assays but did not change confluence, whereas 3K further enhanced cytotoxicity in all 3 assays. Analysis of LDH release versus tetramer-abrogation showed a significant correlation dependent on the number of E/K mutations ( Figure 1F ). Thus, inserting tetramer-lowering E/K mutations in 3 adjacent KTKEGV motifs led to much more T:M ratio lowering and attendant cytotoxicity than any single mutation.
To examine in vivo the amplifying nature of the 3K mutation and its relevance to hu PD, we performed a comparative analysis of our novel 3K transgenic (tg) mice to a genomically humanized fPD E46K mouse (see STAR Methods) and to new hu WT aS mice ( Figure 2A ). We had previously described a method to trap the cell-lysis-sensitive tetramers by intact-cell crosslinking of fresh, minced brain tissue bits with the cell-penetrant crosslinker disuccinimidyl glutarate (DSG) . Similar to our cell-culture studies (Figure 1 ), the E46K (1K) mouse brain had a significant decrease in the T:M ratio versus WT (p < 0.05), and it was further lowered in the 3K brain (p < 0.01, one-way ANOVA, post Tukey) ( Figures 2B and 2C ). Sequential extractions of cerebral cortex (without crosslinking) revealed a shift from buffer-soluble (cytosolic) aS to more TX-solubilized aS (membrane fraction) in 1K versus WT cortex, and this shift was increased further in 3K cortex (Figures S1A and S1B). These changes in tetramerization and solubility between WT, 1K, and 3K were observed despite similar total hu aS brain levels, using a hu aS-specific ELISA on the 3 genotypes ( Figure 2D ) and by immunostaining brains with the hu aS-specific 15G7 ( Figure 2E ). The stepwise K mutant decreases in T:M ratio were confirmed in an additional lower-expressing 3K line (line #3798) we bred to homozygosity (designated 3KL +/+ ; Figures S1C, S1E, and S1F).
Because our present and prior studies in cultured neurons identified the 3K mutant to strongly decrease tetramer levels and induce more cytotoxic aS-positive inclusions , we focused our analyses on the higher expressing 3K mouse (line #3817), since it can be compared to the expression-matched WT line (line #3877). By using antibodies (Abs) against hu and hu + mouse aS, we quantified an $2-fold overexpression of hu 3K aS compared to endogenous aS (Figures S1G and S1H), and this achieves a total aS level similar to that of hu brain (Paleologou et al., 2009 ). We used intact-cell crosslinking (see above) to evaluate whether the 3K variant caused a major decrease in aS tetramers and related multimers and increase in monomers in brain regions relevant for motor function. Comparing the 3K and WT hu aS mice, we found a large and significant decline of the T:M ratio in all brain regions analyzed (p < 0.01, n = 5; Student's t test) (Figures 2F and 2G) . Densitometry of 3K aS60 showed either a trend (striatum, p = 0.2) or a significant reduction (substantia nigra [SN], p = 0.039; cortex, p = 0.013) in T:M compared to the WT brain levels. In accord, 3K aS brains showed a clear-cut excess of monomers: 58% in striatum (p < 0.01), 51% in SN (p < 0.01), and 41% in cortex (p < 0.05) versus the respective monomer levels in the expressionmatched WT hu aS mice ( Figure 2G ).
Next, we sequentially extracted homogenates of key brain regions in buffers of increasing solubilization strength, thereby separating the TBS-soluble fraction (cytosolic) from the Triton X-100-solublized membrane fraction; the TX-insoluble membrane pellets were then solubilized in RIPA. Whether blotting with abs specific for the C-terminal region of hu aS (15G7; aa 116-131) or detecting both rodent and hu aS (C20), the 3K mutation led to significantly less aS in cytosol and more in the TX-soluble and TX-insoluble fractions versus the corresponding levels in the WT and 1K brains ( Figures 2H, 2I , S1A, and S1B). Thus, the 3K mutation markedly reduced the cytosolic T:M ratio (due to both decreased tetramers and increased monomers) ( Figures 2F and 2G) , with the excess monomers having decreased solubility in physiological buffer and enhanced association with membranes ( Figures 2H and 2I ). Moreover, a substantial amount of aS accumulated in the TX-insoluble fraction ( Figure 2H , right panel), with a clear difference in the pattern of these SDS-stable oligomers ( Figure S1D ) from that of the DSGcaptured native aS multimers ( Figure S1C ). In addition, we observed minor aS species in 3K brains migrating just below the major full-length monomers that were immunoreactive with C20 (to a large C-terminal region) but not with 15G7 (to the extreme C terminus) ( Figures 2H and 2I ). We designate this C-terminally truncated hu species DC-aS (confirmed by MS below). Small amounts of DC-aS were detectable in cortex, striatum, and nigra, were relatively higher in the Tx-insoluble than TX-soluble and cytosol fractions, and were consistently greater ($15% increase) in 3K than WT brains ( Figure 2I ). DC-aS species occur in PD and/or aS tg rodents (e.g., Nuber et al., 2014; Nuber et al., 2013; Mishizen-Eberz et al., 2005) and can arise in part from calpain-1 cleavage. Activating calpain-1 could have at least two adverse effects: cleaving aS and thereby enhancing its aggregation and neurotoxicity, and inhibiting autophagy and thus the (B) Intact-cell crosslinking of aS in cortical brain bits from WT, 1K, and 3K tg mice. Syn1 detects monomeric (aS14) and tetrameric (aS60) aS and probable conformers of the tetramer (aS80, aS100) . DJ-1 monomers/dimers serve as control for equal crosslinking and actin for loading. Note the decrease in tetramers associates with a stepwise increase in monomers in 1K and 3K versus WT. (C) Quantification of WBs like those in (B) reveals significant decreases in T:M ratio in 1K versus WT and 3K versus WT (n = 3 mice per genotype, 3 individual experiments). (D) hu-specific aS ELISA show equal aS levels in cortical brain homogenates of 6-month-old WT, 1K, and 3K mice (n = 3). proteolytic degradation of aS (Nuber and Selkoe, 2016) . To assess whether calpain-1 might contribute to the DC-aS species, hu WT and 3K brains were analyzed by mass spectrometry (MS). MS detected hu aS tryptic fragments spanning aa 13-119 in the 3K brain (and containing the 3 E/K mutations); this fragment matched a calpain-1 generated fragment of recombinant, N-acetylated, and fibrillized hu aS ( Figure S1I ) that served as a positive control. Only shorter (aa 35-96) hu DC-aS fragments were seen in the hu WT mouse brain ( Figure S1J ). DC-aS aa 1-119 has been identified in PD brain (Liu et al., 2005) ].
The Tetramer-Monomer Shift Caused by the 3K Mutation Is Associated with a Progressive Motor Syndrome with Multiple Features of PD Our initial breeding of the 3K tg line soon revealed spontaneously developing behavioral changes that included abnormal gait and gradually worsening head and body tremor. At weaning ($1 month), 3K male and female mice showed no apparent motor phenotype, but in the next 2-4 months, all 3K mice developed an increasingly apparent body tremor (Video S1 for 6-month males; Video S2 for 6-month females; Video S3 for 10-month males; Video S4 for 12-month females). In general, the motor syndrome appeared earlier and increased more robustly in the male 3K mice. Indeed, the body tremor of 3K males interfered with breeding after the age of $2 months. Thus, 3K females were used to maintain the nascent heterozygous colony, precluding their inclusion in our initial motor behavior longitudinal analyses. Tremor was the most striking feature of the age-dependent motor phenotype. To quantify its degree, we made 8-to 10-s videos of 6-month-old 3K versus the expression-matched hu WT aS mice and stacked (superimposed) $60 frames, which were converted to a stack mode ''mean'' to sum the extent of body movement.
This method approximates the distance of movement between the captured profiles of the animal's back and also their sharpness ( Figures 3A and 3D ). By age 6 months, 3K mice had a stiff, uncoordinated gait, which was preceded by hind limb clasping that began at $3-4 months ( Figures 3B and 3D ). At age 3 months, 3K mice trended toward less spontaneous movement during open-field (OF) testing, and this became significantly reduced at 6 months versus the age-and aS level-matched hu WT mice (Figure 3E) . The lack of coordinated limb movement was substantiated by a markedly impaired ability of 3K mice to maintain balance while walking on a slowly accelerating rotarod ( Figure 3E ) both at 3 and 6 months. In a pole-climbing task, 3-and 6-month 3K mice had an increased number of falls after turning downward on the pole (3K versus WT 6 months: p < 0.001) that progressed with age (3K 3 versus 6 months, p = 0.01), and a rise in the time to climb down the pole ( Figure 3C ) (Video S5 for pole performance of a 3K male at 6 months; Video S6 for pole performance of an agematched WT male). We detected none of these motor deficits in the expression-matched WT hu aS mice at all time points ( Figures  3A-3E ).
Excess aS Monomers Associate with Vesicles and Are Truncated, Phosphorylated, and Proteinase K Resistant in 3K Mouse Brain To assess neuropathological changes associated with the shift of tetramers to excess, buffer-insoluble and partially truncated monomers ( Figure 2 ) and the accompanying progressive motor deficits (Figure 3 ), we searched for proteinase K (PK)-resistant aS in cryostat sections of striatum, midbrain/SN and motor cortex (mCx). In 6-month 3K mice, PK-resistant aS granules/dot-like structures were detected in the neuropil of striatum and cerebral cortex, whereas in age-and hu aS level-matched WT controls, the much lower amounts of aS accumulation displayed less or no PK resistance ( Figures  4A and 4B ). In the 3K midbrain and mCx, dense round perikaryal inclusions were observed, often situated near the nucleus, and some of these were partially PK resistant, whereas only background staining was observed in the simultaneously processed WT hu aS brain sections (Figures 4A and 4B) .
To confirm that the abundant aS monomers in 3K brain ( Figure 2G ) form PD-relevant pathological aggregates, we applied a monoclonal antibody (mAb) (51253, Abcam) specific for phosphorylated (pSer129) aS or a mAb (105, gift of W. Zago, Prothena Biosciences) favoring the detection of C-terminally truncated (DC) aS. Both modifications are commonly detected in hu Lewy pathology and mouse models thereof (e.g., Nuber and Selkoe, 2016) . We observed dot-like patterns in cortical neuropil with both mAbs, staining of round and granular perikaryal deposits in midbrain neurons, and dots and varicosities in the striatal neuropil ( Figure 4C ).
To address the ultrastructural correlates of the abnormal aS-immunoreactive profiles in the neuropil and neuronal somata, we prepared ultrathin sections for immunogold labeling. Consistent with the many, small dot-like inclusions detected by light microscopy in 3K mouse neuropil, we readily identified a co-localization of the 3K mutant aS with membrane vesicles in synaptic boutons, while far fewer gold particles were seen in the expression-matched WT hu aS brains ( Figure 4D , higher magnification in lower panels). We quantified these data: there were no differences in vesicle numbers per se; however, significantly more total gold particles and particles per vesicle occurred in the 3K synaptic boutons than in the expressionmatched hu WT brains ( Figure 4E ).
To further assess whether the rising level of aS cytopathology correlated with the progressive motor abnormalities and was a feature of both 3K and familial PD (fPD) E46K, we compared these changes in the 3K, 1K, and hu WT aS tg mice at 3 versus 6 months ( Figure 5 ). Notably, we found a significant multi-fold rise in pSer + labeling as early as 3 months in 3K versus 1K and WT mice ( Figures 5A, 5B , and 5D). By 6 months, levels in 3K mice had risen to very high levels, and 1K mice now also showed a small ($2-fold) but significant rise versus 3 months ( Figure 5A Figure 5D ). Interestingly, by age 6 months, somewhat less pSer129 + neuropil fibers but more perikaryal inclusions with this feature were observed in cortical neurons of the 3K mice (less noticeably in the 1K mice) ( Figure 5B ). To substantiate this apparent neurite loss, we impregnated cortical tissue blocks with Golgi-Cox solution, providing a 3-dimensional view of some neurons and their processes. We observed shortened neurites and less dense dendritic arbors by Golgi-Cox in the pyramidal neuropil of 3K cortex (Figure 5C ), a reduced neurite pattern also reported from loss of DAergic cortical input in a 6-OH DA rat model (Solis et al., 2007) . Quantifying the percentage of area of neuropil covered by Golgi-Cox-impregnated neurons revealed a small but significant decrease in 6-month 3K mice ( Figure 5D ). The timedependent pSer129 accumulation and neurite loss was associated with decreased performance in pole climbing at $3 and 6 months ( Figure S2A ). For example, the smaller increase in pSer129 + aggregates in 1K mice at 6 months was associated with an intermediate pole performance (not reaching significance versus WT or 3K) ( Figures 5D and S2A ). Compared to these data on the male 3K mice, female 3K mice developed motoric phenotypes (versus gender-matched hu WT mice) by age 6 months (exemplified by the challenging rotarod test; Figure S2B ) and neurochemical changes (aS pSer129 + aggregates; Figure S3A ), but at a slower rate. Similarly, a lower expressing 3K line (3KL +/+ ) displayed an intermediate phenotype ( Figure S2C ; see below).
By quantitative immunoblotting, we observed a robust $3-fold rise of pSer129 + aS in 3K over hu WT in whole-brain extracts at 6 months ( Figure S3A ). We further evaluated pSer129 + accumulation in cerebellar and cortical sections, since increasing evidence suggests their involvement in PD-related tremor (Caligiore et al., 2016) . We found more abundant and age-dependent accumulation of pSer129 + aS in 3K cortical regions, whereas relatively minor pSer129 + aS immunoreactivity occurred in 3K cerebellar cortex ( Figure S3B ). pSer129 + inclusions were also detected in some DAergic and/or noradrenergic TH-positive perikarya, including in SN and locus coeruleus and occasionally in the ventral tegmental area (VTA) ( Figure S3C ), but we detected no significant loss of TH + VTA cells in 3K mice at 6 months ( Figure S3D ), a neuronal selectivity that again resembles PD. Homozygous 3K Mice Have Severe Motor Deficits that Preclude Survival after Weaning, while a Second, Lower-Expressing 3K Line Shows Deficits Intermediate between 1K and 3K Lines To assess whether high levels of toxic aS 3K monomers in the brain that derived from two copies of the tetramer-abrogating 3K construct further increases pathology, we attempted breedings between 3K heterozygous mice. One 3K male was able to fertilize a 3K female, producing 4 homozygous (3K +/+ ) pups. Their severe motor phenotype was apparent shortly after birth and led to their being unable to reach food and water independently after weaning, thus requiring euthanasia by age $4 weeks) ( Figure S3E ; Video S7). By immunoblotting brain extracts, we observed a doubling of monomer levels versus 3K +/À mice (data not shown). A striking finding of these 3K +/+ mice was the severe pSer129 + aggregation pathology already at 4 weeks, twice the level of the 3K +/À line at the same age (Figures S3F and S3G) . Their hu aS aggregates co-localized with LAMP-1 (data not shown), suggesting they accumulated with lysosomes. Further phenotyping was precluded by the small number of pups born and their very brief survival.
To validate the striking PD-like phenotypes described so far in our 3K +/À line, we characterized mice from a second and lowerexpressing 3K line (line #3798) that had been generated simultaneously from the same 3K transgene. This low-expressing line is designated 3KL, and the males bred normally, in contrast to the breeding deficit of the high-expressing 3K males. Accordingly, the 3KL line could be bred to homozygosity, yielding 3KL +/+ mice, and we have performed limited phenotyping of these. By both neuropathological and motor assessments, the 3KL +/+ mice displayed phenotypes that were intermediate between the 1K and 3K mice: brain extracts showed a significant decrease in T:M ratio (Figures S1C, S1E, and S1F). Brain sections analyzed simultaneously from our four mouse lines showed a stepwise accumulation of pSer129 + deposits in neuronal perikarya and neuropil (WT < 1K < 3KL +/+ < 3K) ( Figures S3H and S3I) . The challenging rotarod test revealed that 3KL +/+ mice began to show a small but significant age-dependent motor impairment at 8 months versus age-matched Ntg controls, but this was far less than in the 3K line at 6 months ( Figure S2C ). The generation of homozygous 3K pups, as well as the independent tetramerdeficient 3KL +/+ line from the same transgene and its intermediate phenotype, rules out insertional mutagenesis as an artifactual explanation for the phenotype observed in our principal 3K line.
aS 3K Monomers Accumulate at Vesicles in Synapses and Cell Bodies that Also Display Lipid-Rich Deposits of Endo-Lysosomal Origin Electron microscopy (EM) analyses of the 3K mice revealed aS gold immunoreactivity closely adjacent to both small synaptic vesicles ($60 nm) and larger, perinuclear vesicles ($300 nm).
To explore the ultrastructure of the intraneuronal deposits further, we performed conventional and immunogold EM in mCx and SN of 3K and hu WT aS mice at 3 months. 3K mice had medium-and large-sized lipofuscin-like deposits that were less abundant in WT neurons, which exhibited more finely granular deposits ( Figure 6A ). The 3K deposits often contained lipid droplets ( Figure 6A, white arrowheads) . The deposits were often single-membrane bound and closely associated with late endo-lysosomal structures such as multivesicular bodies ( Figure 6A , white asterisks). Some deposits showed aS immunoreactivity associated with the vesicular membrane ( Figure 6A , black arrowheads) and contained lamellar membrane whorls typical of late endosomes/lysosomes ( Figure 6A , upper-right panel, black asterisk), accumulating in close proximity to the nucleus (Figure 6A, lower-right panel) . Abnormally sized endo-lysosomes have been found to accumulate LAMP-1 foci embedded within pSer129 + inclusions in aS culture models of PD (Volpicelli-Daley et al., 2014) and are a common feature of fPD and sporadic PD (sPD) (Kett and Dauer, 2016) . Also, previous neuropathological analyses described accumulations of such vesicles close to (Watanabe et al., 1977) or as part of (Forno, 1996) hu LBs, and their sizes have been postulated to increase in early Lewy-type pathology (Kuusisto et al., 2003) . Hypothesizing an early Lewy-like pathology from our tetramer-lowering aS mutations, we quantified the lipofuscinlike deposits by double staining our sections with the neuronal cytoskeleton marker bIII-tubulin and the late endo-lysosomal membrane marker LAMP-1 ( Figure 6B ) and analyzed both LAMP-1 accumulation and autofluorescence. A significant (>2-fold) accumulation of LAMP-1 was observed in 6-monthold 3K mutant mice (for LAMP-1 single staining, see Figure 6C ; graph in Figure 6D ), and the neurons often contained an increase in autofluorescent aggregates typical of lipofuscin deposits (Figures 6C and 6D ). We next immunostained sections for synaptotagmins, which are widely used markers for vesicular membranes and are implicated in calcium-dependent exocytosis (Cheng et al., 2015) . While synaptotagmin-1 (syt-1) is localized to small synaptic vesicles, synaptotagmin-7 (syt-7) localizes to the neuronal plasma membrane and lysosomes (Zhang et al., 2011) ; thus, these two markers can help differentiate between vesicular pools. As expected from our ultrastructural findings of aS-rich vesicular accumulations ( Figures 4D and 4E ), 3K aS monomers strongly co-localized with syt-1 at nerve terminals and with syt-7 in neuronal somata, while much less co-localization was detected in the expression-matched hu WT aS brain ( Figures S4A and S4B) . To validate the finding, we conducted co-staining for syt-7 and LAMP-1. We found these markers co-localized in the aS-immunoreactive neuronal inclusions and in some enlarged processes in the 3K mice, but these were less apparent in WT and 1K (fPD) aS mice (Figure S4C) . The finding of an age-and K-dependent progressive increase of vesicle-rich aS + lesions going from WT to 1K to 3K brains was further supported by quantifying the large foci of co-reactivity for either pSer129 and LAMP-1 ( Figures 6E and  6F ) or syt-7 and total (15G7 + ) hu aS (1K-3 months versus 1K-6 months: p < 0.05; 3K-3 months versus 3K-6 months: p < 0.0.001; one-way ANOVA, post Tukey) ( Figure 6F) .
Vesicle-and lipid-rich granules such as we observe in the 3K brain are reported to accumulate in midbrain and cortical neurons in PD and DLB and are hypothesized to contribute to the formation of mature Lewy bodies over time (Meredith et al., 2004) . Thus, we searched for Lewy-type inclusions in the oldest 3K male mouse available to date (16 months). We found infrequent large ($8 mm diameter) spherical inclusions close to the nucleus in neuronal somata of cortex and midbrain ( Figure S5A ). These Lewy body-like inclusions had a lipofuscin-rich center surrounded by densely packed filamentous material that was immunoreactive with the 15G7 hu aS ( Figure S5B ). We also observed scattered dark, degenerated neurons and synapses in 3K cortical and midbrain sections and degenerated synapses and neurons that contained large intraneuronal lipid deposits ( Figure S5C ). (D) Quantification of LAMP-1 reactivity and autofluorescent deposits in cortical neurons of 6-month 3K versus WT mice (n = 10 fields each of brain sections from n = 3 mice per genotype). (E) Confocal microscopy of cortical brain sections labeled for pSer129-aS (red) and LAMP-1 (green) as indicated. (F) Top: colocalized points were analyzed using ImageJ colocalization highlighter and particle analyzer plugin and quantification (n = 3 mice per genotype at 3 and 6 months). Bottom: Adjacent brain sections labeled for hu (15G7) aS and syt-7 ( Figure S4) were quantified for co-localized aggregate sizes in n = 10 fields each of sections from each genotype. Note significant age-dependent increases in 1K and 3K but not in the age-and [aS]-matched WT mice. Means ± SEM. *p < 0.05, **p < 0.01 (D: unpaired 2-tailed Student's t test; (F) one-way ANOVA post Tukey. Scale bars in (A), 1 mm, in (B) 25 mm, and in (C) and (E), 20 mm.
3K Mice Have Dopaminergic Neurodegeneration, and the Associated Motor Deficits Are Partly Responsive to L-DOPA
To assess whether the pathological accumulation of 3K aS monomers at synaptic vesicles and endo-lysosomes and the associated motor phenotype correlated with a decrease in DAergic integrity, we quantified tyrosine hydroxylase (TH) immunopositive axons and their terminals. We conducted the studies in male mice, since subtle differences in sex hormones can contribute to variances between male and female mice in neurochemistry (e.g., estrogen facilitates dopamine neurotransmission; Barth et al., 2015) .
We analyzed the dorsal striatum (caudate/putamen, CPu), which is rich in projections from the DAergic neurons of the SN pars compacta (SNpc). We measured an $30% reduction in the density of TH + fibers in 6-month-old 3K mice compared to age-and expressionmatched WT hu aS mice, which were in turn indistinguishable from Ntg mice ( Figures 7A and 7B ). Since nerve fiber degeneration may precede DAergic cell loss in PD (Cheng et al., 2010) , we used unbiased stereological cell counting of TH-immunopositive neurons in the SNpc of 6-month 3K versus hu WT tg mice and Ntg littermates. In addition to the significant decrease of TH-positive striatal fibers, we found a substantial reduction of TH-positive SNpc neurons ($27%; p < 0.01) in 3K compared to Ntg mice ( Figure 7B ). In addition to the loss of TH-immunopositive striatal terminals and nigral cell bodies, 3K mice displayed an $39% decrease of striatal DA measured by HPLC (p < 0.01 versus Ntg) ( Figure 7B ). We also observed a trend toward reduced striatal DA in the WT hu aS tg mice by HPLC measurements ($20%, p = 0.09 versus Ntg). The WT mice had no significant reduction in TH fibers, and their decrease in SNpc somata missed reaching significance ( Figure 7B ). Notably, we found a discrete punctate pattern and numerous larger hu aS-immunopositive aggregates throughout the dorsal striatum and in the vicinity of SN DAergic neurons in 3K versus WT mice ( Figure 7C, with graphs) , consistent with our EM finding of a significant increase in hu aS accumulation on synaptic vesicles ( Figures 4D and 4E) . In light of the reduction in TH fibers in 3K striatum, we asked whether other dopaminergic synaptic markers were decreased. In addition to TH, striatal protein levels of the vesicular marker VMAT-2 showed significant reductions (p < 0.05) ( Figure 7D ), further substantiating degeneration of the dopaminergic neuropil.
Given the numerous phenotypic parallels of the 3K mice to PD, we analyzed the effects of L-DOPA treatment on motor coordination in the pole-climbing test and in the regularity of the step pattern on a treadmill (quantified by gait analysis software), using a blinded, randomized crossover trial. We used a relatively low dose of L-DOPA previously published to ameliorate a moderate DAergic phenotype and avoid induction of stereotypic behaviors in mice (e.g., Chartoff et al., 2001) . A single L-DOPA injection significantly improved pole test performance of the 3K mice, as measured by a decrease in falls while turning on the pole as well as a shorter time to climb down the pole ( Figure 7E : 3K-Sal versus 3K-DOPA, p < 0.01). L-DOPA treatment also reduced clasping and improved performance on a 4-limb wire hanging test, suggesting that it improved muscle tone in 3K mice ( Figure S6A ). However, L-DOPA did not improve the highly abnormal 3K performance on the rotarod ( Figure S6A ) and did not noticeably alter the tremor (as can be the case in L-DOPA-treated PD), suggesting a contribution from the clear-cut cortical pathology to these motor phenotypes. The deficits in wire hanging, in addition to changes in gait patterns and pole climbing (Videos S1, S2, S3, S4, S5, and S6) suggest abnormalities in the functional coupling of the limbs in 3K mice. We therefore photographically analyzed the fine paw patterns of mice running on a motorized belt. Saline-treated 3K mice displayed a significant abnormality of hind and front paw coupling and a decrease in the regularity of steps ( Figure 7E : WT-Sal versus 3K-Sal, p < 0.001 for hind/front paw coupling and p < 0.05 for the overall step regularity index). 3K mice also showed less normal diagonal body support (2-paw body support), while three-paw support was significantly increased, suggesting an insecure gait ( Figure S6B ). Importantly, L-DOPA treatment normalized the impaired paw coupling ( Figure 7E : 3K-Sal versus 3K-DOPA p < 0.001) and the regularity of steps ( Figure 7E : 3K-Sal versus 3K-DOPA p < 0.05). Moreover, L-DOPA-treated 3K mice significantly increased their diagonal body support ( Figure S6B) , and the stance graphs of the same 3K mouse treated with saline or L-DOPA revealed a marked improvement in gait after L-DOPA, with no such difference in the normal WT aS tg mice ( Figure S6C ).
DISCUSSION
Creating faithful animal models of human neurodegenerative disease is critical for therapeutic development but has proved to be a major challenge. For PD, DLB and related synucleinopathies, we describe a new mouse line that has an excess of membrane-bound pathogenic monomers derived from the unique approach of lowering a physiological form of aS, the a-helical tetramer. This results in multiple features of PD at the neuropathological, biochemical, and behavioral levels.
Chronically Shifting Normal Tetramers to Excess Monomers In Vivo Is Associated with a PD-like State
Consistent with studies from our and other labs (Table S1) , we detect physiological tetramers and related multimers in healthy, intact brain tissues of non-tg and WT hu aS tg mice ( Figures 2B-2G ), and these animals do not develop features of PD. Our intact-cell crosslinking approach confirms a significant decrease of intracellular tetramers and increase in monomers in mice with the fPD E46K (1K) mutation, and a much greater lowering of the T:M ratio in mice with an amplification of this fPD mutant (3K), in accord with previous findings and new data (Figure 1) in cultured neural cells. The phenotypes of the 1K and 3K lines are not due to differences in aS expression, as aS levels are similar and both were even slightly lower than in the hu WT tg brains ( Figure 2D ). The only fPD E46K (1K) line available for this study expressed a bacterial artificial chromosome (BAC) construct that includes the entire hu aS gene, in contrast to the transgene encoding just the hu aS protein in our 3K line. A disadvantage of this comparison is that the 3K line lacks the hu regulatory elements that the 1K line has. On the other hand, the two lines have closely matching overexpression of hu aS, and the fact that there is a graded effect of hu WT versus 1K versus 3K across the 3 lines means that distinct expression constructs (BAC versus transgene) can each produce the biochemical phenotype. We observe all of our key PD-like changes in the 1K versus WT line, and these changes are more robust in the 3K mice, with all 3 lines having similar aS expression. The changes documented in the 1K mice include a significant shift in the T:M ratio (Figures 2 and S1 ), Ser129 phosphorylation ( Figures 5 and S3 ), age-dependent inclusion formation ( Figures 5 and 6) , and motor signs ( Figure S2 ). The lesser amount of pathogenic 1K aS monomers is a result of the smaller decrease in T:M ratio, as expected from just one E/K substitution in the aS amphipathic helix, and as we established in our earlier culture work on 1K versus 2K versus 3K and confirmed with our new data in Figure 1 . While only the 1K is driven by the hu aS regulatory sequences (BAC construct), one can view this as a molecular biological plus, in that we observe PD-type changes from the loss of aS tetramers in an entirely independent line.
The shift from cytosolic to membrane-associated aS by the 3K mutation is observed both biochemically (Figures 2 and S1 ) and ultrastructurally ( Figures 4D and 4E) . The robust PD-like posttranslational modifications of aS in 3K mice notwithstanding, the decrease in the brain T:M ratio was the largest biochemical change we observed in this mouse ($70% decrease versus WT hu aS) ( Figures 2B-2G ) and was already present by age 3 months ( Figure 2B ). However, this may not be the common pathogenic mechanism of all fPD-causing missense mutations, as the documented T:M decreases of A30P and G51D aS involve amino acid changes that result in less, not more, membrane association and thus act independently of an increase in membrane affinity. Interestingly, CD spectroscopy of WT and fPD recombinant aS showed decreasing a-helical content in the order WT > A30P > A53T > E46K , closely resembling the relative decreases in cellular T:M ratios of our previous neuronal culture studies . The reported ages of onset of clinical symptoms in carriers of the five fPD missense mutations (Kr€ uger et al., 1998; Appel-Cresswell et al., 2013; Proukakis et al., 2013) may also agree in general with the relative decrease in T:M ratio in our culture studies. Therefore, creating new mouse models with an amplified effect of G51D on the T:M ratio could help clarify the PD-biochemical mechanisms apparently occurring in the absence of the enhanced membrane binding seen with E46K.
The central finding of this study is that an excess of monomers resulting from amplifying the known tetramer-lowering effect of the E46K mutation by inserting analogous mutations into two adjacent KTKEGV motifs can induce vesicle-rich, aS-containing aggregates, and this leads to agedependent aS neuropathology associated with a progressive motor phenotype including prominent resting tremor and deficits in limb function and gait that respond in part to L-DOPA. DAergic SNpc neuron loss (versus VTA neurons) coupled with decreases in striatal TH fibers and DA levels as well as prominent cortical aS aggregates and degeneration of the cortical neuropil underlie the tremor and limb and gait deficits that resemble cardinal features of hu PD. Intriguingly, although 3K male and female mice have similar aS expression levels ( Figure S1 ), 3K male mice have more prominent motor changes than 3K females (Figure S2) , reminiscent of what occurs in hu PD. Several studies have reported sex differences in PD clinical profiles that manifest in women with delayed average onset (by $2 years) and slower rate of motor decline and more tremor, whereas rigidity is more prominent in men (Gillies et al., 2014) , and female sex hormones are reported to facilitate striatal dopamine neurotransmission (Barth et al., 2015) . aS is normally involved in membrane vesicle trafficking, and altered aS-membrane interaction is emerging as a key factor in PD (Logan et al., 2017) . Thus, sex hormones likely contribute to the male/female differences in severity of our 3K mice, an important topic to address further using this line.
Decreases in the aS Tetramer:Monomer Ratio May Underlie Certain Genetic Forms of PD Before 2011, aS was assumed to exist as a natively unfolded monomer in cells, although it was long known that recombinant monomers could become a-helically folded in vitro upon contact with small, highly curved lipid vesicles (Davidson et al., 1998) . We and others (Table S1) reported evidence that a portion of cellular aS existed in apparent a-helical tetramers if isolated under nondenaturing conditions or crosslinked in vivo with cell-penetrant crosslinkers. We found that the tetramers were highly metastable, as cell lysis disassembled them unless performed at high protein concentrations (''molecular crowding'') . This suggests the presence of a ''limiting factor,'' perhaps a small lipid, that stabilizes the tetramers in vivo. Tetramers are soluble and physiological (b-and g-synuclein also exist as tetramers), and neurons require a normal T:M equilibrium to avoid excess monomers misfolding into abnormal oligomers, which can be associated with clustering of cytoplasmic vesicles into round inclusions associated with neurotoxicity (Dettmer et al., , 2015b .
aS missense mutations that cause aggressive, early-onset forms of fPD have all been shown to decrease the T:M ratio in neurons, including in induced pluripotent stem cell (iPSC)-derived hu neurons at endogenous expression levels and in A53T transgenic mouse brain . Recently, hu neurons bearing Gaucher-causing mutations in GBA1 were found to also shift endogenous WT aS tetramers to excess monomers, and the decreased T:M ratio could be corrected by genetic or pharmacological lowering of the accumulated glucosylceramide (Kim et al., 2018) . This striking finding (replicated in our group [U.D. et al., personal communication] ) strongly supports the relevance of the T:M equilibrium to ''sporadic'' PD, since GBA1 loss-of-function mutations are a major genetic cause of PD, and such patients were previously considered to be part of idiopathic PD. Importantly, aS is wild-type in Gaucher's carriers and patients, so pathogenic shifts in the T:M ratio do not require mutating the protein. These hu genetic findings, coupled with the striking PD-like phenotypes of our tetramer-abrogating mice, support a new paradigm for PD pathogenesis in which a disturbed T:M equilibrium can lead to progressive synucleinopathy.
Here, we correlated a shift of aS T:M ratio with the development of PD-relevant neurotoxicity in vivo. The significant decreases in both TH protein and DA neurotransmission ( Figure 7B ) as well as the abnormal Golgi-Cox stained neuropil in the 3K cortex ( Figure 5C ) suggest that cell and fiber loss from abrogating tetramers is likely mediated by the pathological vesicle association of the excess monomers.
C-Terminal aS Truncation and pSer129 Phosphorylation
Are Consequences of a Pathogenic T:M Shift C-terminally truncated aS species are reported to increase significantly in fPD (Li et al., 2005) , sPD, and DLB hu brains (Anderson et al., 2006; Nuber et al., 2013 Nuber et al., , 2014 , and they may promote aggregation of aS (Mishizen-Eberz et al., 2005) and induce DAergic neuronal dysfunction in models (Tofaris et al., 2006) . Our findings that a DC-aS truncation site in 3K brains matches a calpain-1 cleavage site (aa 119) of pure, fibrillized aS in vitro and that this DC truncation is prevented by a calpain-specific inhibitor in neural cells expressing the tetramerlowering 3K or 3R mutants (S.N. and D.S., unpublished data) suggest that calpain-1 activity contributes to pathological C-terminal truncation in our PD models.
The predominant post-translational modification of 3K aS, however, is extensive Ser129 phosphorylation (Figures 4, 5, 6, and S3 ). This modification is prominent in fPD (Lesage et al., 2013) and DLB (Obi et al., 2008) as well as in various tg models, including mice overexpressing fPD A53T or A30P aS (Wakamatsu et al., 2007; Schell et al., 2009) . The increases in pSer reactivity and inclusion sizes seen in 1K mice are markedly augmented by the excess monomers in heterozygous 3K +/À mice and even more so in homozygous 3K +/+ mice, and the hyperphosphorylation is associated with phenotypic progression, consistent with a positive correlation between accumulation of the pSer129 modification and the severity of PD symptoms in humans (Walker et al., 2013 ).
An Early, Functionally Relevant Dopaminergic Deficit in the Tetramer-Abrogating 3K Mice
To our knowledge, the early DAergic deficiency, resting tremor, and progressive limb and gait impairments partially responsive to L-DOPA are unique for a PD mouse model (Table S1) , thus representing a useful model for mechanistic studies and therapeutic screening. In cultured neurons, modestly increased expression of WT aS not exceeding the levels in hu brain allows retention of the physiological T:M ratio and preserves neuronal integrity . Consistent with this concept, expression of WT aS (Richfield et al., 2002) or expressing the single E46K (1K) fPD mutant by conventional transgenesis (1-to 2-fold above endogenous aS) caused only subtle neurological deficits in aged ($20 months) homozygous mice or else required an additional insult with PD-related neurotoxins (Emmer et al., 2011; Cannon et al., 2013) , whereas doublemutant (A30P + A53T) hu aS promotes frank cytopathology in mouse brain (Table S2 ). In contrast to single-mutant (1K) tg rodents in prior reports (Emmer et al., 2011; Cannon et al., 2013) and the present study, 3K synucleinopathy is readily apparent beginning at 3 months, and the resultant decreases in nigrostriatal TH + somata and fibers and increases in less soluble and more phosphorylated aS coincide with an earlyonset, progressive motor syndrome.
Membrane Alterations and aS Filamentous Inclusions Resembling Lewy Bodies Occur in 3K Mice
Our data demonstrate that 3K monomers interact with vesicular membranes more than WT aS, and this includes synaptic vesicles and endo-lysosomal structures that co-label for LAMP-1 and syt-7. Synaptotagmins (syt) are calcium-sensitive proteins capable of aggregating membranes and thereby stimulating fusion if soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors (SNARE) complexes are in place (Hui et al., 2011) . Since aS monomers can stabilize some membranes against fusion (Westphal and Chandra, 2013) , monomer accumulation could perturb neurotransmission and alter endolysosomal protein degradation, particularly in neurons with high calcium flux (Burbulla et al., 2017) . The increase in LAMP-1 puncta that co-localize with pSer + aggregates and associate with endo-lysosomal changes in our 3K mice (Figures 6 and S4) may serve as an early feature of eventual Lewy-type pathology (Volpicelli-Daley et al., 2014) . In hu EM studies, such lysosomal/vesicle accumulation was observed in fPD and sPD and discussed as a potential step toward formation of so-called pale bodies and perhaps later Lewy bodies (Kuusisto et al., 2003) . Our new model did not display clear-cut accumulation of filamentous aS lesions at age 6 months, but a few appeared in the areas of aS-rich vesicle clusters at a much later age (16 months).
Thus, the presence of vesicle accumulations and elevated full-length, truncated, and phosphorylated aS monomer levels in PD patient brains support the PD relevance of both the T:M shift and the ensuing round, phosphorylated cytoplasmic inclusions that are robust features of our middle-aged mice and may be a prerequisite to developing mature Lewy-type inclusions at an older age.
Implications of the New Mouse Model for Mechanistic and Therapeutic Studies of PD and DLB
Mechanistically, we hypothesize that the reason this new mouse model closely mirrors key features of hu PD (Table S1) is that the underlying event-chronically altering the neuronal T:M equilibrium-is likely to occur in PD, DLB, and other hu synucleinopathies. Genetic evidence for this concept comes from hu fPD aS missense mutations and now from GBA deficiency (Kim et al., 2018) . A recent analysis of the molecular mechanism underlying 3K and other tetramerreducing mutations suggests an alteration of proper transient formation of the amphipathic helix that is induced in WT aS by membrane binding . Previous experimental studies reported that E46K (1K) aS has a higher affinity for binding to negatively charged vesicles than does WT aS (Choi et al., 2004) , likely via abnormally increased, membrane-induced amphipathic helix formation (Wise-Scira et al., 2013) , and may thereby lead to aS oligomer cytotoxicity (Winner et al., 2011) ; 3K may enhance this abnormality. Thus, reversible aS tetramerization and amphipathic helix formation appear to regulate a normal, transient vesicle-binding function of aS (Wang et al., 2014) , and abrogating normal tetramers interferes with this function and has pathogenic consequences, as we now show in vivo.
Finally, the therapeutic implications of the recapitulation of numerous PD phenotypes in the 3K mice include screening for small molecules that can stabilize physiological tetramers or decrease the levels of excess full-length and truncated and/or pSer129 phosphorylated monomers and their associated vesicle aggregates. The reproducibility of inclusion formation and neuronal dysfunction in both cultured cells and living mice undergoing tetramer-to-monomer disequilibrium provides a combined in vitro and in vivo platform to discover and validate such compounds. This approach could be analogous to the successful biochemical stabilization of physiological tetramers of transthyretin by the approved drug, tafamadis, which has clinical benefits for patients with that progressive amyloidosis (Coelho et al., 2013) . In addition, our mouse models can be used to identify and characterize small molecules that enhance the clearance of aS inclusions and otherwise normalize the several PD-like posttranslational modifications of aS by restoring the physiological T:M ratio.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: with FITC-conjugated secondary Abs (1:1000 in PBS) for 4 hours at RT. Confocal microscopy was conducted with an Axiovert 35 microscope (Zeiss) mounted on a MRC1024 laser scanning confocal microscope (Bio-Rad). For confocal images of either syt-1, syt-7 or TH with 15G7-reactive hu-aS, each image was color-balanced. An ImageJ plug-in called ''Colocalization highlighter'' created a mask of either syt-7, LAMP-1 or TH pixels that overlapped with hu-aS pixels. The sizes of the co-localized pixels on the resultant 8-bit images were quantified using the analyze particle function plugin of ImageJ. For Golgi-Cox stainings, brains of n = 6 mice per group were dissected from the skull and incubated in rapid Golgi-Cox solutions for 14 days, following manufacturer's instructions (FD Rapid GolgiStain Kit, FD Neurotechnologies).
Electron microscopy
Mice underwent transcardiac perfusion with 4% PFA and the dissected brains were fixed in 4% PFA for another 48 h, subsequently in 2% PFA for 24 h, and then transferred into 0.5% PFA. Dissected brain regions were quenched with 0.2 M glycine in PBS for 10-15 min at RT and then permeabilized by washing for several times in PBS containing 0.1% Triton X-100 (PBST), then blocked for 30 min in 1% (w/v) bovine serum albumin in PBST at RT. A rat anti-hu aS Ab (15G7,1:50, Enzo) in PBST containing 1% BSA was added to sections and incubated overnight at 4 C. Sections were washed five times for 10 min in PBS followed by incubation with rabbit anti-rat bridging Ab (1:100 Abcam ab6703) in PBS containing 1% BSA for 1h at room temperature, then washed five times in PBS, followed by incubation with 15 nm Protein A-gold particles (1:50, Utrecht University Med Ctr) in PBS containing 1% BSA for an hour at room temperature. Sections were subsequently washed in PBS and then fixed in 1% (v/v) glutaraldehyde in PBS for 30 min. For Epon embedding, slices were incubated in 0.5% (w/v) osmium in ddH 2 O for 30 min, washed three times in ddH 2 O then stepwise dehydrated (each step for 10 min) in 70% (v/v) ethanol, 95% (v/v) ethanol and twice in 100% (v/v) ethanol. The slices were incubated in propyleneoxide, infiltrated in 1:1 propylenoxide/TAAB Epon, embedded in fresh TAAB Epon (Marivac Canada Inc) and polymerized at 60 C for 48 h. Each block was cut into 60 nm ultrathin sections using a Reichert Ultracut-S microtome. Sections were placed onto copper grids and stained with uranyl acetate and lead citrate. The sections were examined using a JEOL 1200EX transmission electron microscope. Images were recorded with an AMT 2k CCD camera at 20,000-30,000 3 magnification.
Assessment of striatal DA fiber integrity and stereological counting 40-mm-free floating sections were rinsed in TBS (0.15M NaCl, 0.1M Tris-HCl, pH 7.5) and endogenous peroxidase activity quenched with 0.6% H 2 O 2 in TBS for 30 min at RT. Unspecific protein binding was blocked with 3% normal donkey serum in TBS containing 0.3% Triton X-100. Sections were incubated with rabbit TH (AB152, 1:500, Millipore) over night at 4 C. Following 3 rinses with TBS, sections were incubated with secondary anti-rabbit (1:1000, Dianova 711-065-152) in TBS containing 3% normal donkey serum, washed, and subsequently transferred into ABC solution (1:500 in PBS; Vectastain Elite Kit, Vector Laboratories) for 1 h and visualized with 3,3 0 -diaminobenzidin (DAB). Brain sections across a +4.8 to +3.5 interaural range were chosen, referring to the Paxinos and Franklin mouse brain atlas (Paxinos and Franklin, 2001) . Sections from all genotypes were simultaneously stained and digitized using constant imaging settings (Stereoinvestigator, MicroBrightField, Colchester, VT), and subsequent analyses were performed on a blinded basis. Images were converted to gray scale, and the mean gray value intensity was measured in the caudate/putamen (CPu) and in the adjacent corpus callosum (cc) to correct for signal background. Mean gray values were converted to uncalibrated optical density (UOD) using ImageJ 1.46r software (NIH). The UOD of TH signal in the CPu was calculated by the formula CPu final(UOD) = CPu (UOD) -cc (UOD) , similar to a previously published study (Schlachetzki et al., 2014) . For stereological counting, every fourth free-floating section of 40 mm thickness, encompassing the full rostro-caudal extent of the SN or ventral tegmental area (VTA), was stained for TH (for 36 h) as described above. This approach resulted in 9 to 10 sections in which the SN or VTA was identified. The number of TH positive neurons in the SN pars compacta (SNpc) or VTA of one hemisphere was stereologically assessed using the optical fractionator principle and using the Stereo Investigator software (MicroBrightField, Colchester, VT). The region of interest was outlined using a 2.5 3 objective and sampled with a 40 3 objective using a square optical frame (SNpc and VTA: 50 3 50 mm) and sampling grid (SNpc: 60 3 60 mm and VTA: 75 3 75 mm), with 2 mm guard zones above and below the counting. The estimated coefficient of error (Gundersen, m = 1) ranged from 0.05 to 0.07, and the estimated section thickness was $19 mm. The reported ''total'' number of TH positive neurons is the number estimated by number-weighted section thickness multiplied by a factor of 2, representing both hemispheres.
Behavioral testing
Tremor assessment Tremor assessment was conducted by an investigator blinded to the genotype. To measure the depth of tremor in 6 mo old 3K and WT mice (n = 6 per group), we used short-term (8-10 s) video recording of mice standing on a small platform (5x3cm) (thus excluding gross posture changes) and subsequent stacking of $60 frames. The layers were converted to a smart object and then to the stack mode 'mean' in order to sum the body movements in a single frame image using Adobe Photoshop software. This method allowed evaluation of the distance between the captured tremulous spine images, which were inverted for clarity. The contrast of the tremulous spine images after inversion was used to evaluate their 'sharpness' by ImageJ pixel intensity measurement.
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